Skip to main content
Clinical Trials/NCT02010398
NCT02010398
Completed
Not Applicable

Neurophysiological, Dynamometric, Functional and Clinical Assessment of the Cross-Training Effect in Patients With Multiple Sclerosis

Università degli Studi di Sassari3 sites in 1 country45 target enrollmentJuly 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
Università degli Studi di Sassari
Enrollment
45
Locations
3
Primary Endpoint
Muscular strength
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this study is to determine whether, in patients with multiple sclerosis presenting with marked asymmetry of strength, training the less-affected limb with a Cross-Training approach may induce a meaningful transfer of strength with neurophysiological, functional and clinical correlates, to the contralateral, more-impaired limb.

Detailed Description

Muscle weakness is a major disability that is responsible for deeply reducing the overall quality of life (QoL) of patients with Multiple Sclerosis (MS). Research has shown that strength training (ST) has a significant positive effect on the performance of daily living activities in people with MS, resulting in an increased QoL. Several ST methods are currently employed for reducing strength impairment in MS but no one regimen has been portrayed as superior to others. When strength impairment is prominently lateralized to one limb, training is commonly addressed to the weaker side in order to balance the deficit. However, such ST may not always be applicable to a severely weakened limb that is too compromised to sustain it. For these selected patients we hypothesize that training the less affected limb with a Cross Training (CT) approach may overcome the problem, also avoiding patients' frustration and potential withdrawals from rehabilitation programs. Aim of this project is to investigate and compare in two groups of selected MS patients, with a marked asymmetry of strength, the effects induced on dynamometric, neurophysiological, functional and clinical outcomes by a CT of the less-impaired leg (CT group) compared to a ST of the more-impaired leg (ST group). In order to make comparisons with a population which is not exposed to the condition MS, a third group composed of healthy subjects will also be included in the study. The research plan will be articulated in 5 phases (recruitment, baseline assessment, 6 week-intervention phase, post-intervention assessment and follow up at 12 weeks).

Registry
clinicaltrials.gov
Start Date
July 2013
End Date
March 27, 2017
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Università degli Studi di Sassari
Responsible Party
Principal Investigator
Principal Investigator

Professor Franca Deriu

Associate Professor

Università degli Studi di Sassari

Eligibility Criteria

Inclusion Criteria

  • Age: 18-65 years
  • Expanded Disability Status Scale (EDSS) ≤6 (Pyramidal functional system ≥3)

Exclusion Criteria

  • Clinically relevant cognitive disorders;
  • Disability caused by other diseases;
  • Medication with corticosteroids within three months prior to enrolment;
  • Medication with botulinum toxin within six months prior to enrolment;
  • Clinically or radiologically documented exacerbation within six months prior to enrolment;
  • Variations in disease-modifying drugs (DMD) within three months prior to enrolment;
  • Severe ataxia and postural instability (assessed with Berg Balance Scale);
  • Depression

Outcomes

Primary Outcomes

Muscular strength

Time Frame: Muscular strength will be assessed at baseline, within one week from the completion of the 6-week rehabilitation phase and at 12-week follow up.

Strength changes in the weaker side compared to the contralateral, through isokinetic dynamometry.

Secondary Outcomes

  • Neural adaptations to Cross Training(Neural adaptations will be assessed at baseline, within one week from the completion of the 6-week rehabilitation phase and at 12-week follow up.)

Study Sites (3)

Loading locations...

Similar Trials